Additionally, the surface marker EpCAM was identified in the past to play a crucial role in HCC, as it is associated with shorter overall survival rates and higher rates of portal vein invasion and is enriched in the invasive border of HCCs [26,54]. This evidence concerns the gene EPCAM and hepatocellular carcinoma.